AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26728036 — intervention group
Group type: COMPARATOR
Intervention: Unloaded screws
Number of subjects: 51
Study 26728036 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study 25065692 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0
Study 25065692 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 0
Study 22592508 — intervention group
Group type: EXPERIMENTAL
Intervention: Ari+Val
Number of subjects: 42
Study 22592508 — intervention group
Group type: COMPARATOR
Intervention: Hal+Val
Number of subjects: 42
Study 19922703 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical pimecrolimus
Number of subjects: 40
Study 19922703 — intervention group
Group type: COMPARATOR
Intervention: Topical hydrocortisone
Number of subjects: 40
Study 18408345 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing assistance tools (a mat with attached handles, a pair of trousers with knee pads and a waist holding belt)
Number of subjects: 41
Study 15486338 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnography
Number of subjects: 288
Study 15486338 — intervention group
Group type: COMPARATOR
Intervention: Home monitoring
Number of subjects: 288
Study 12509177 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypermedia software presentation on basic functions of the human body
Number of subjects: 72
Study 12509177 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear, electronic book mode
Number of subjects: 72
Study 12509177 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed brochure
Number of subjects: 72
Study 12509177 — intervention group
Group type: COMPARATOR
Intervention: Regular lectures and materials (Control group)
Number of subjects: 72
Study 10624823 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine hydrobromide, 0.3 mg, i.v.
Number of subjects: 13
Study 10624823 — intervention group
Group type: COMPARATOR
Intervention: Glycopyrrolate, 0.2 mg, i.v.
Number of subjects: 13
Study 8538922 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine 10 mg daily for 1 week
Number of subjects: 12
Study 8538922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1934868 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate supplementation (1 mg/day) during methotrexate therapy
Number of subjects: 0
Study 1934868 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 1934868 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Folate and Placebo)
Number of subjects: 0
Study 7074555 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide excision and immediate node dissection
Number of subjects: 553
Study 7074555 — intervention group
Group type: COMPARATOR
Intervention: Wide excision and delayed node dissection
Number of subjects: 553
Study 30734207 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg subcutaneously every 2 weeks (Q2W), with dose increase to 150 mg Q2W at week 12 if LDL-C was >= 70 mg/dl
Number of subjects: 1257
Study 30734207 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg Q2W
Number of subjects: 1257
Study 30734207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1257
Study 30734207 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 1257
Study 30048657 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF/Carb/silica, NaF/silica, NaF + MFP/chalk
Number of subjects: 0
Study 30048657 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF/Carb/silica, NaF + MFP/dical, AmF/silica
Number of subjects: 0
Study 30048657 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF/Carb/silica, NaF + SnF2/silica/HMP
Number of subjects: 0
Study 30048657 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 ppm F)
Number of subjects: 0
Study 30048657 — intervention group
Group type: COMPARATOR
Intervention: 675 ppm F as NaF (675F-NaF) ± Carb
Number of subjects: 0
Study 30048657 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF/carb/silica
Number of subjects: 0
Study 30048657 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF + SnF2/silica/HMP
Number of subjects: 0
Study 26259809 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV F vaccine (60 or 90 µg) with or without aluminum phosphate adjuvant, 1 or 2 doses
Number of subjects: 330
Study 26259809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study 24101715 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate therapy group using the 'Exploring Feelings' manual (Attwood, 2004) for seven weekly sessions.
Number of subjects: 32
Study 24101715 — intervention group
Group type: COMPARATOR
Intervention: Delayed therapy group (control).
Number of subjects: 32
Study 22436198 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (herpes simplex virus-suppressive therapy)
Number of subjects: 1305
Study 22436198 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive use
Number of subjects: 1305
Study 19473149 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration stimulus during local anaesthetic injections
Number of subjects: 0
Study 19473149 — intervention group
Group type: COMPARATOR
Intervention: No vibration stimulus during local anaesthetic injections
Number of subjects: 0
Study 19473149 — intervention group
Group type: EXPERIMENTAL
Intervention: Infiltration anaesthetic injection with vibration
Number of subjects: 0
Study 19473149 — intervention group
Group type: EXPERIMENTAL
Intervention: Block anaesthetic injection with vibration
Number of subjects: 0
Study 16980070 — intervention group
Group type: EXPERIMENTAL
Intervention: Antilymphocyte globulin (n = 50)
Number of subjects: 100
Study 16980070 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-IL-2R monoclonal antibody (n = 50)
Number of subjects: 100
Study 16980070 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 100
Study 14666010 — intervention group
Group type: EXPERIMENTAL
Intervention: Total circulatory arrest
Number of subjects: 160
Study 14666010 — intervention group
Group type: COMPARATOR
Intervention: Low-flow cardiopulmonary bypass
Number of subjects: 160
Study 11200745 — intervention group
Group type: COMPARATOR
Intervention: Opiate abusers (group II) after treatment
Number of subjects: 180
Study 11200745 — intervention group
Group type: COMPARATOR
Intervention: Opiate abusers (group II) before and after treatment
Number of subjects: 180
Study 11200745 — intervention group
Group type: COMPARATOR
Intervention: Alcohol abusers (group I) before treatment
Number of subjects: 180
Study 11200745 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study 8775172 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock-absorbing inserts
Number of subjects: 517
Study 8775172 — intervention group
Group type: COMPARATOR
Intervention: Not issued inserts (Control)
Number of subjects: 517
Study 8775172 — intervention group
Group type: EXPERIMENTAL
Intervention: Purchased inserts on their own
Number of subjects: 517
Study 1469671 — intervention group
Group type: EXPERIMENTAL
Intervention: Reticulose
Number of subjects: 53
Study 1469671 — intervention group
Group type: COMPARATOR
Intervention: Placebo (physiological saline)
Number of subjects: 53
Study 6487441 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 4 ml in 8% glucose
Number of subjects: 30
Study 6487441 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 4 ml in 5% glucose
Number of subjects: 30
Study 6487441 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine 4 ml in 0% glucose (glucose-free solution)
Number of subjects: 30
Study 6487441 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 4 ml in hyperbaric solutions (8% and 5% glucose)
Number of subjects: 30
Study 31463720 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-scope POEM
Number of subjects: 100
Study 31463720 — intervention group
Group type: COMPARATOR
Intervention: Single-scope POEM
Number of subjects: 100
Study 31113718 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord blood sampling (5 mL from the placental end of the umbilical cord)
Number of subjects: 80
Study 31113718 — intervention group
Group type: COMPARATOR
Intervention: Admission blood sampling (from the neonate upon NICU admission)
Number of subjects: 80
Study 27485803 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% lidocaine injection
Number of subjects: 52
Study 26237827 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Traditional Chinese Medicine (TCM) therapy including shenfu injection (60 mL) and deproteinized calf blood injection (DCBI) (1.2 g) for Yang-Qi deficiency; shenmai injection (60 mL) and DCBI (1.2 g) for Yin-Qi deficiency, once daily for 21 days.
Number of subjects: 66
Study 26237827 — intervention group
Group type: COMPARATOR
Intervention: Aricept (5 mg, once daily)
Number of subjects: 66
Study 23748313 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent abutment (test group)
Number of subjects: 16
Study 23748313 — intervention group
Group type: COMPARATOR
Intervention: Healing abutment (control group)
Number of subjects: 16
Study 23748313 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study 22379904 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 22
Study 22379904 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary atrium-femoral bypass
Number of subjects: 22
Study 22379904 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 22
Study 19845435 — intervention group
Group type: EXPERIMENTAL
Intervention: bifendate (three times daily for 14 days)
Number of subjects: 16
Study 16953055 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunlight exposure for one hour per day for twenty days (n=8)
Number of subjects: 414
Study 16953055 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation, 50,000 IU per day for twenty days (n=7)
Number of subjects: 414
Study 16953055 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as those not receiving either intervention)
Number of subjects: 414
Study 14998601 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision-aid booklet 'Birth Choices: What is best for you...vaginal or caesarean birth?'
Number of subjects: 21
Study 14998601 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 21
Study 11482555 — intervention group
Group type: EXPERIMENTAL
Intervention: RMT (n = 13)
Number of subjects: 28
Study 11482555 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 15)
Number of subjects: 28
Study 9922810 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic total extraperitoneal repair (Group II)
Number of subjects: 64
Study 9922810 — intervention group
Group type: COMPARATOR
Intervention: Open preperitoneal herniorraphy (Group I)
Number of subjects: 64
Study 8060584 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 8
Study 8060584 — intervention group
Group type: COMPARATOR
Intervention: Trichlormethiazide
Number of subjects: 8
Study 2647124 — intervention group
Group type: EXPERIMENTAL
Intervention: Short contact dithranol in stiff emulsifying ointment base
Number of subjects: 16
Study 2647124 — intervention group
Group type: COMPARATOR
Intervention: Short contact dithranol in stiff Lassar's paste
Number of subjects: 16
Study 2647124 — intervention group
Group type: EXPERIMENTAL
Intervention: Stiff emulsifying ointment
Number of subjects: 16
Study 29767639 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir (TFV) reduced-glycerin 1% gel applied vaginally for 14 days
Number of subjects: 14
Study 29767639 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir (TFV) reduced-glycerin 1% gel applied rectally for 14 days
Number of subjects: 14
Study 29767639 — intervention group
Group type: COMPARATOR
Intervention: Cervicovaginal lavage fluid and rectal fluid collected 24 hours after dosing
Number of subjects: 14
Study 28098723 — intervention group
Group type: EXPERIMENTAL
Intervention: Group M (ERM removal only)
Number of subjects: 26
Study 28098723 — intervention group
Group type: COMPARATOR
Intervention: Group L (ERM and ILM removal)
Number of subjects: 26
Study 28098723 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (surgical dye identification)
Number of subjects: 26
Study 26525473 — intervention group
Group type: COMPARATOR
Intervention: Physiological solution (group 1)
Number of subjects: 160
Study 26525473 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% xylometazoline solution (group 2)
Number of subjects: 160
Study 26525473 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% lidocaine solution (group 3)
Number of subjects: 160
Study 26525473 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% xylometazoline and 10% lidocaine mixture (group 4)
Number of subjects: 160
Study 24117425 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Practical intervention package including intensive education, consultation services, maintenance of an epilepsy tracking card, and repeated reminders.
Number of subjects: 360
Study 24117425 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - No intervention package.
Number of subjects: 360
Study 24117425 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Medical compliance rating.
Number of subjects: 360
Study 24117425 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - Medical compliance rating.
Number of subjects: 360
Study 24117425 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between changes in AED adherence and seizure control.
Number of subjects: 360
Study 24117425 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between changes in lifestyle and seizure control.
Number of subjects: 360
Study 21262002 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Number of subjects: 50
Study 21262002 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 50
Study 19058678 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-step selective enamel etching (Syntac SE)
Number of subjects: 80
Study 19058678 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-step self-etching adhesives
Number of subjects: 80
Study 19058678 — intervention group
Group type: COMPARATOR
Intervention: Etch-and-rinse (Syntac ER)
Number of subjects: 80
Study 19058678 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching adhesives
Number of subjects: 80
Study 19058678 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching adhesives under etch-and-rinse conditions
Number of subjects: 80
Study 16689008 — intervention group
Group type: EXPERIMENTAL
Intervention: Total glucosides of Paeony (TGP) and leflunomide (LEF)
Number of subjects: 80
Study 16689008 — intervention group
Group type: COMPARATOR
Intervention: Leflunomide (LEF) alone
Number of subjects: 80
Study 12960786 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufflation pressure of 8 mm Hg (LC8)
Number of subjects: 40
Study 12960786 — intervention group
Group type: COMPARATOR
Intervention: Insufflation pressure of 15 mm Hg (LC15)
Number of subjects: 40
Study 12960786 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LC8 and LC15)
Number of subjects: 40
Study 11128825 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid effervescent 1000 mg
Number of subjects: 374
Study 11128825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374
Study 9547437 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20-40 mg
Number of subjects: 4444
Study 9547437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4444
Study 9547437 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 4444
Study 8279689 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (n = 50)
Number of subjects: 100
Study 8279689 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (n = 50)
Number of subjects: 100
Study 3595696 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol withdrawal
Number of subjects: 39
Study 3595696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 31147972 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectus sheath block with ropivacaine (Group B, n=25)
Number of subjects: 100
Study 31147972 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial loading dose of 0.6 μg kg‐1 dexmedetomidine, followed by continuous infusion of 0.2 μg kg‐1 h‐1 (Group D, n=25)
Number of subjects: 100
Study 31147972 — intervention group
Group type: EXPERIMENTAL
Intervention: Both rectus sheath block and dexmedetomidine (Group BD, n=25)
Number of subjects: 100
Study 31147972 — intervention group
Group type: COMPARATOR
Intervention: Neither rectus sheath block nor dexmedetomidine (Group C, n=25)
Number of subjects: 100
Study 30056782 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuffed endotracheal tubes
Number of subjects: 12
Study 30056782 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sealing baffled endotracheal tubes
Number of subjects: 12
Study 27631136 — intervention group
Group type: EXPERIMENTAL
Intervention: Balaglitazone
Number of subjects: 297
Study 27631136 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 297
Study 27631136 — intervention group
Group type: COMPARATOR
Intervention: Lower tertile of endotrophin levels
Number of subjects: 297
Study 23884342 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 34
Study 23884342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 22408775 — intervention group
Group type: EXPERIMENTAL
Intervention: At-home bleaching with 10% carbamide peroxide
Number of subjects: 40
Study 22408775 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office bleaching with 35% hydrogen peroxide without a light source
Number of subjects: 40
Study 22408775 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office bleaching with 35% hydrogen peroxide with quartz-tungsten-halogen light
Number of subjects: 40
Study 22408775 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office bleaching with 35% hydrogen peroxide with light-emitting diode/laser
Number of subjects: 40
Study 19085526 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐ and email‐based treatment programme for social phobia (Shyness programme)
Number of subjects: 0
Study 19085526 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet treatment
Number of subjects: 0
Study 19085526 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of Internet treatment
Number of subjects: 0
Study 17983942 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5mg/day (Livial)
Number of subjects: 100
Study 17983942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 16335199 — intervention group
Group type: EXPERIMENTAL
Intervention: Plum-blossom needle therapy combined with cupping
Number of subjects: 64
Study 16335199 — intervention group
Group type: COMPARATOR
Intervention: TDP radiation
Number of subjects: 64
Study 11966554 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane/nitrous oxide mixture
Number of subjects: 411
Study 11966554 — intervention group
Group type: COMPARATOR
Intervention: Nitrous oxide alone
Number of subjects: 411
Study 9808914 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron (50 mg dissolved in 100 ml of milk, administered twice a day)
Number of subjects: 20
Study 7695315 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine-clindamycin combination regimen
Number of subjects: 100
Study 7695315 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine-doxycycline combination regimen
Number of subjects: 100
Study 7695315 — intervention group
Group type: COMPARATOR
Intervention: Quinine monotherapy
Number of subjects: 100
Study 1673134 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol, 100 mg twice daily
Number of subjects: 19
Study 1673134 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 1673134 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 19
Study 37852 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol (20 mg)
Number of subjects: 72
Study 37852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 31866099 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouse allergen reduction (75% or greater decrease in mouse allergen levels)
Number of subjects: 350
Study 31866099 — intervention group
Group type: EXPERIMENTAL
Intervention: Less than 75% allergen reduction
Number of subjects: 350
Study 31621667 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI with postconditioning (repeated transient balloon occlusion after establishment of flow)
Number of subjects: 43
Study 31621667 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI with postconditioning
Number of subjects: 43
Study 31621667 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional primary PCI)
Number of subjects: 43
Study 31621667 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study 28882709 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-endoscopic interlaminar approach (FEIA)
Number of subjects: 44
Study 28882709 — intervention group
Group type: COMPARATOR
Intervention: Open minimally invasive microsurgical technique (MMST)
Number of subjects: 44
Study 25992523 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam (6 mg)
Number of subjects: 0
Study 25992523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23497676 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaglucan
Number of subjects: 100
Study 23497676 — intervention group
Group type: EXPERIMENTAL
Intervention: sodium hyaluronate (Neoviderm®)
Number of subjects: 100
Study 23497676 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitis vinifera A. s‐I‐M.t‐O.dij (Ixoderm®)
Number of subjects: 100
Study 23497676 — intervention group
Group type: EXPERIMENTAL
Intervention: Alga Atlantica plus Ethylbisiminomethylguaicolo and Manganese Cloruro (Radioskin1®)
Number of subjects: 100
Study 23497676 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal Esculetina plus Ginko Biloba and Aloe vera (Radioskin 2®)
Number of subjects: 100
Study 23497676 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural triglycerides‐fitosterols (Xderit®)
Number of subjects: 100
Study 23497676 — intervention group
Group type: EXPERIMENTAL
Intervention: Selectiose plus thermal water of Avene (Trixera+®)
Number of subjects: 100